BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2501838)

  • 1. The effect of fleroxacin on hepatic drug metabolism in the rat.
    Grech-Bélanger O; Francoeur J; Le Bel M
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):121-33. PubMed ID: 2501838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive effect of amiodarone on hepatic drug metabolism in the rat.
    Grech-Bélanger O
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):15-30. PubMed ID: 6729246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
    Augustine JA; Zemaitis MA
    Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effect of isoflurane on drug metabolism: decreased type I and increased type II substrate metabolism in guinea pig liver microsomes.
    Rahman MM; Fujii K; Kawamoto M; Yuge O
    J Appl Toxicol; 1996; 16(4):331-7. PubMed ID: 8854220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
    McLellan RA; Drobitch RK; Monshouwer M; Renton KW
    Drug Metab Dispos; 1996 Oct; 24(10):1134-8. PubMed ID: 8894516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism in a reconstituted system by diabetes-dependent hepatic cytochrome P-450.
    Past MR; Cook DE
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):81-90. PubMed ID: 6812187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):588-95. PubMed ID: 6149909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
    Kato Y; Kimura R
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential properties of the microsomal deamination and hydroxylation reactions.
    Bélanger PM; Lalande M; Atitsé-Gbeassor A
    Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):429-41. PubMed ID: 6622818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platinum and palladium salts on parameters of drug metabolism in rat liver.
    Holbrook DJ; Washington ME; Leake HB; Brubaker PE
    J Toxicol Environ Health; 1976 Jul; 1(6):1067-79. PubMed ID: 966317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs.
    Ritter JK; Franklin MR
    Drug Metab Dispos; 1987; 15(3):335-43. PubMed ID: 2886308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of x-rays on the level, composition and para-nitroanisole-o-demethylase activity of cytochrome P-450 in the liver microsomes of rats].
    Deev LI; Akhalaia MIa; Vasilenko OV; Platonov AG; Topchishvili GI
    Radiobiologiia; 1984; 24(5):612-5. PubMed ID: 6505149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.